Here are five outcomes from the Symmetry Medical stockholders meeting where these decisions were made:
1. The stockholders present representing 85.7 percent of outstanding shares of common stock in Symmetry Medical voted to approve a definitive merger agreement among Symmetry Medical, TecoStar, Tecomet and TecoSym, which was dated Aug. 4, 2014. There were 8.8 percent in favor and 0.38 percent opposed.
2. As a result of the merger, Symmetry Medical will sell its OEM Solutions business to Tecomet affiliates and the concurrent transfer to Symmetry Medical stockholders of shares in a new company holding the Symmetry Surgical business.
3. There were stockholders representing 57.86 percent of the outstanding shares of common stock of Symmetry Medical who voted to approve certain compensation payable or that could become payable to Symmetry Medical’s executive officers.
4. Around 67 percent of the voters agreed to pass the measure on compensation while 31.83 percent were opposed; 0.99 percent abstained.
5. Symmetry Medical expects to complete the transaction promptly. The company is still subject to customary closing conditions.
More articles on orthopedic devices:
DePuy Synthes Spine Receives FDA clearance for thoracic insufficiency syndrome rib devices
Medtronic-Covidien merger surges ahead: Chinese Ministry of Commerce clears proposed acquisition
10 trends in the bone graft market
